$AHR

American Healthcare REIT (AHR) Q2 2026 Earnings Call Transcript

American Healthcare REIT (AHR) reported Q2 2026 GAAP net income of $30.6 million ($0.16/share) and normalized FFO of $0.54/share, up 28.6% year over year. Total same-store NOI grew 13.2% and guidance for NFFO per share was raised to $2.15-$2.19. Full-year same-store NOI guidance raised to 11%-13%.

Original reporting
Published Aug 13, 2026, 11:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 11:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
American Healthcare REIT (AHR) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$AHRBullishMed
01

Why it matters

The newest actionable information is the set of raised 2026 guidance ranges (NFFO per share and segment same-store NOI) supported by strong same-store NOI growth and improved leverage, tempered by explicit seasonality risks and low outpatient medical growth guidance.

02

Market read

Traders can update valuation and positioning based on the raised NFFO and same-store NOI guidance, plus the stated leverage improvement and acquisition funding plan.

03

What to watch

The transcript highlights liquidity and forward sales as funding for acquisitions, so traders should watch whether deal pipeline execution and forward sales timing match the raised guidance assumptions.

Relevance 8/10Novelty 8/10Timing: post-market, after-hours earnings call transcript for Q2 2026

Background

The article is a transcript of American Healthcare REIT’s Q2 2026 earnings call, covering operating results, capital deployment, balance sheet, and full-year 2026 guidance.

Company-level read

Ticker impact

$AHRBullishMedium confidence
Context

American Healthcare REIT raised 2026 NFFO per share guidance to $2.15 to $2.19 and lifted same-store NOI growth ranges.

Expected impact

Likely supportive for the stock on guidance credibility, with focus on whether occupancy seasonality and outpatient softness offset the raised outlook.

Evidence & confidence

The call discloses multiple forward-looking guidance revisions (NFFO and segment NOI ranges) alongside operating KPIs (same-store NOI growth, margins, occupancy) and balance-sheet metrics (net debt to EBITDA 2.5x). The main offset risk is stated skilled nursing occupancy seasonality and outpatient medical guidance near-flat.

Market effects

Reinforces the senior housing and integrated health operating model with continued double-digit same-store NOI growth and margin expansion, potentially supporting sector sentiment.

Mentions Midwest-heavy skilled nursing exposure and winter seasonality risk, which could matter for investors focused on regional occupancy trends.

Limited direct global linkage; primarily US healthcare REIT fundamentals and capital markets access.

Counterpoint

Raised guidance may still be vulnerable to winter-driven occupancy and expense seasonality, especially given outpatient medical guidance is only 0% to 1% and skilled nursing occupancy can pull back.

Key entities

  • American Healthcare REIT, Inc.

    Subject of the earnings call transcript; management reported Q2 operating growth and increased full-year 2026 guidance.

  • Jeff Hanson

    CEO who emphasized scaling the platform and described acquisitions as high-quality infill assets.

  • Gabe Willhite

    President and COO who discussed segment performance, margins, and occupancy seasonality risks.

  • Brian Peay

    CFO who addressed leverage, liquidity, and expense growth expectations.

Related articles

$AHRMedAI 8/10

Why is American Healthcare REIT stock sliding today?

American Healthcare REIT (AHR) shares fell about 4.5% pre-open to $53 after the company priced an underwritten public offering of 13.25M shares via forward sale agreements, raising about $712.2M gross before expenses. Underwriters can buy 1.99M more shares. Proceeds target a senior housing portfolio acquisition, investments, and general purposes. Analysts reiterated Market Outperform and a $65 price target.

$AHRMedAI 8/10

American Healthcare REIT prices $712M stock offering

American Healthcare REIT (NYSE:AHR) priced an underwritten public offering of 13.25 million common shares via forward sale agreements, expecting about $712.2 million in gross proceeds before expenses. The deal may add 1.9875 million shares via a 30-day option. Proceeds are expected on physical settlement about 24 months later for an operating partnership acquisition and other uses.

$AHRMed

American Healthcare REIT Continues ‘Next Level of Growth’ With SHOP Deals

American Healthcare REIT (AHR) raised its projected investment pipeline to $800 million from $650 million (May). In Q2, it completed $126.9 million of SHOP investments, taking yearly SHOP investments to $1.4 billion. Same-store SHOP NOI grew 20.5% y/y. AHR also reported a $197.5 million in-process development and expansion pipeline, with $72 million funded, and its stock rose 3.71% to $56.74.

$AHRMedAI 8/10

American Healthcare REIT Posts Strong Q2 2026 Results; Raises Full Year 2026 Guidance

American Healthcare REIT reported Q2 2026 GAAP net income attributable to controlling interest of $30.6 million, or $0.16 per diluted share, and NFFO attributable to controlling interest of $0.54 per diluted share. Same-store NOI rose 13.2% YoY. The company raised FY 2026 guidance, including NFFO per diluted share to $2.15-$2.19, and declared a $0.25 quarterly common dividend.

$AHRMedAI 8/10

AMERICAN HEALTHCARE REIT ($AHR) Releases Q2 2026 Earnings

American Healthcare REIT (AHR) reported Q2 2026 earnings on Aug. 6. The company posted EPS of $0.54 versus an estimate of $0.17, and revenue of $670.96 million versus $669.80 million. The article also cites recent insider sales and institutional position changes, plus a median analyst price target of $57.